Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer. 2021

Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
Department of Gynecological Oncology and Tumor Surgery, European Competence Center for Ovarian Cancer, Charité Campus Virchow Clinic, Berlin, Germany.

OBJECTIVE To demonstrate the prognostic value of pleural carcinosis/effusion in a cohort of patients with advanced epithelial ovarian cancer (EOC) and the associated therapeutic implications. METHODS Overall, data for 388 patients with EOC with confirmed malignant pleural effusion (MPE) or pleural carcinosis were retrospectively analyzed. Exclusion criteria were non-epithelial ovarian malignancies and presence of other comorbidities associated with pleural effusions. RESULTS The prognosis after the occurrence of MPE during the EOC in relapsed cases was poor with an overall survival of 9.9 months. In the multivariate analysis, the time point of the manifestation of the pleural effusion (p<0.001), platinum sensitivity (p=0.003), performance status (p=0.045) and presence of ascites (p=0.004) were significant prognostic factors for overall survival. CONCLUSIONS Even in this less favorable collective, well-established EOC prognostic factors were associated with a significantly better overall survival. This suggests that the overall behavioral pattern of the disease has strong similarities in patients with and without pleural effusion or carcinosis and merits an equally high therapeutic effort.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010997 Pleural Neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. Neoplasms, Pleural,Neoplasm, Pleural,Pleural Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077216 Carcinoma, Ovarian Epithelial A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer. Epithelial Ovarian Cancer,Epithelial Ovarian Carcinoma,Ovarian Cancer, Epithelial,Ovarian Epithelial Cancer,Ovarian Epithelial Carcinoma,Cancer, Epithelial Ovarian,Cancer, Ovarian Epithelial,Carcinoma, Epithelial Ovarian,Epithelial Cancer, Ovarian,Epithelial Carcinoma, Ovarian,Epithelial Ovarian Cancers,Epithelial Ovarian Carcinomas,Ovarian Carcinoma, Epithelial,Ovarian Epithelial Cancers,Ovarian Epithelial Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
May 2013, Deutsches Arzteblatt international,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
March 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
January 1970, American journal of obstetrics and gynecology,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
October 2022, Anticancer research,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
January 2016, MicroRNA (Shariqah, United Arab Emirates),
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
July 2018, International journal of cancer,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
May 2006, Cancer treatment reviews,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
March 2024, Cancer cell international,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
January 2010, The breast journal,
Sara Nasser, and Christina Fotopoulou, and Rolf Richter, and Jana Kaulich, and Elena Braicu, and Carmen Beteta, and Jessica Olschewski, and Aygun Babayeva, and Jalid Sehouli
December 1988, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!